
Group 1 - Core Laboratories reported quarterly earnings of $0.19 per share, exceeding the Zacks Consensus Estimate of $0.18 per share, but down from $0.22 per share a year ago, representing an earnings surprise of +5.56% [1] - The company posted revenues of $130.16 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.45%, although this is a decrease from year-ago revenues of $130.58 million [2] - Core Laboratories has underperformed the market, with shares losing about 32% since the beginning of the year compared to the S&P 500's gain of 7.3% [3] Group 2 - The current consensus EPS estimate for the coming quarter is $0.18 on revenues of $126.55 million, and for the current fiscal year, it is $0.71 on revenues of $505.39 million [7] - The Zacks Industry Rank indicates that the Oil and Gas - Field Services sector is currently in the bottom 5% of over 250 Zacks industries, suggesting a challenging environment for companies in this sector [8] Group 3 - The estimate revisions trend for Core Laboratories was unfavorable ahead of the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]